- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02194621
Clinical Investigation to Examine Toothpaste Effect on Oral Bacteria
March 30, 2016 updated by: Colgate Palmolive
A Randomized, Single Center, Three Cell, Double Blind and Parallel Groups Clinical Study Conducted in Newark, NJ to Evaluate the Antibacterial Effects of Two Toothpastes Containing 0.3% Triclosan/2% Copolymer/0.243% Sodium Fluoride in a Silica Base as Compared to a Control Regular Fluoride Toothpaste on Oral Bacteria 12 Hours After 13 Days Product Use.
The primary objective was to evaluate the antibacterial effects of two toothpastes containing 0.3% triclosan, 2% copolymer and 0.234% sodium fluoride in a silica base as compared to a control regular fluoride toothpaste on anaerobic and malodor bacteria 12 hours after 13 days of product use.
A secondary objective was to demonstrate that a toothpaste containing 0.3% triclosan, 2% copolymer, 0.234% sodium fluoride and a flavor with odor-masking ingredients in silica base (Colgate Total Toothpaste-Flavor Option 1) provides a level of antibacterial efficacy that is "equivalent" to a toothpaste containing 0.3% triclosan, 2% copolymer, 0.234% sodium fluoride and a regular flavor in silica base (Colgate Total Toothpaste-Flavor Option 2) after 13 days of product use.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
128
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Newark, New Jersey, United States, 07107
- Rutgers School of Dental Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 56 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Males and females in good general health aged 18 to 70 years.
- A willingness to read, understand, and sign the Informed Consent Form after the nature of the study has been fully explained to them. Subject should demonstrate a willingness to comply with all study procedures and sampling schedules.
- A minimum of 20 natural teeth with facial and lingual scorable surfaces.
- Adequate oral hygiene and no signs of oral neglect.
- Good periodontal health. Enrolled subjects will have no more than five periodontal pockets of 5 mm.
- Subjects with gingival index greater than or equal to 1.0 (Loe-Silness Index) and plaque index greater than or equal to 1.5 (Turesky modification of Quigley-Hein Index) will be enrolled.
Exclusion Criteria:
- History of significant adverse effects following use of oral hygiene products such as toothpastes and mouthrinses. Allergy to personal care/consumer products or their ingredients.
- Teeth that are grossly carious, fully crowned or extensively restored on facial and/or lingual surfaces, orthodontically banded, abutments, or third molars
- History of diabetes or hepatic or renal disease, or other serious medical conditions or transmittable diseases, e.g. heart disease or AIDS.
- History of rheumatic fever, heart murmur, mitral valve prolapse or other conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures.
- Subjects on antibiotic, anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam.
- Significant oral soft tissue pathology, systemically related gingival enlargement, severe gingivitis (based on a visual examinations).
- History of active severe periodontal disease with bleeding gums and loose teeth.
- Gross dental caries, severe generalized cervical abrasion and/or enamel abrasion, large fractured or temporary restorations (based on visual examinations).will not be included in the tooth count.
- Fixed or removable orthodontic appliance or removable partial dentures.
- Participation in a dental plaque/gingivitis clinical study involving oral care products, within the last 30 days. History of dental prophylaxis or treatments in the past month.
- Self reported pregnancy or lactation.
- History or current use of objects to pierce the lips or tongue.
- Subjects known to be an alcoholic, or a recovering alcoholic.
- History or current use of recreational drugs.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Total Flavor Option 1
Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM (oral malodor) complex 1 ingredient - Total Flavor Option 1
|
Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM complex 1 ingredient -Total Flavor Option 1
Other Names:
|
Experimental: Total Flavor Option 2
Total toothpaste containing triclosan/copolymer/sodium fluoride with new OM (oral malodor) complex 2 ingredient.
Total Flavor Option 2
|
Total toothpaste containing triclosan/copolymer/sodium fluoride and new OM complex 2 ingredient.
Total Flavor option 2
Other Names:
|
Placebo Comparator: Crest Toothpaste
Placebo toothpaste: Crest Cavity Protection toothpaste (currently marketed)
|
Placebo toothpaste: Crest Cavity Protection toothpaste w/sodium fluoride (currently marketed)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anaerobic Bacteria
Time Frame: Baseline
|
Subjects brush their teeth with assigned toothpaste 2x/day for 13 days.
On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation.
Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units.
|
Baseline
|
Anaerobic Bacteria
Time Frame: 12 hours
|
Subjects brush their teeth with assigned toothpaste 2x/day for 13 days.
On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation.
Samples of dental plaque at the gumline will be collected for microbiological analysis to determine total levels of anaerobic bacteria CFU - colony forming units.
|
12 hours
|
Malodor Bacteria (Breath Odor Causing Bacteria)
Time Frame: Baseline
|
Subjects brush their teeth with assigned toothpaste 2x/day for 13 days.
On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation.
Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units.
|
Baseline
|
Malodor Bacteria (Breath Odor Causing Bacteria)
Time Frame: 12 hours
|
Subjects brush their teeth with assigned toothpaste 2x/day for 13 days.
On clinic visit day, subjects brush their teeth and return 12 hours later for clinical evaluation.
Samples of dental plaque at the gumline will be collected for microbiological analysis to determine levels of mouth odor causing bacteria CFU - colony forming units.
|
12 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Actual)
March 1, 2014
Study Completion (Actual)
March 1, 2014
Study Registration Dates
First Submitted
July 15, 2014
First Submitted That Met QC Criteria
July 16, 2014
First Posted (Estimate)
July 18, 2014
Study Record Updates
Last Update Posted (Estimate)
April 15, 2016
Last Update Submitted That Met QC Criteria
March 30, 2016
Last Verified
July 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- CRO-1113-BACT-PS-NJ
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Bacteria Levels in the Mouth
-
Mead Johnson NutritionCompletedLevels of DHA in the BloodUnited States
-
Metabolic Technologies Inc.CompletedFocus of the Study is to Examine Plasma HMB Levels After Oral HMB SupplementationUnited States
-
Mead Johnson NutritionUniversity of AlbertaCompletedLevels of Fatty Acids in the Blood Cells of InfantsCanada
-
Cairo UniversityRecruitingOral Lichen Planus | Leptin LevelsEgypt
-
University Health Network, TorontoCompletedUltrasound Airway Imaging in Determining the Oral Cavity and Tongue SizeCanada
-
Uskudar UniversityCompletedInvestigate the Relationship Between the Psychosocial Factors Affecting Pain Perception and Physical Activity Levels in Pregnant Women With Lumbopelvic PainTurkey
-
All India Institute of Medical Sciences, New DelhiWithdrawn
-
Dentsply Sirona ImplantsCompletedPartial Edentulism in the Maxilla or in the MandibleUnited States, Belgium, Germany, Italy
-
Suleyman Demirel UniversityCompletedOral Findings in Children of Multiple and Single Births | Radiographic Evaluation of Oral Findings in Children of Multiple and Single BirthsTurkey
-
Medical College of WisconsinNational Cancer Institute (NCI)Active, not recruitingSquamous Cell Carcinoma of the Oral CavityUnited States
Clinical Trials on Total Flavor option 1
-
Abbott NutritionNational Health Service, United Kingdom; Changing HealthActive, not recruitingType 2 Diabetes | Weight Change, BodyUnited Kingdom
-
Johns Hopkins UniversityMedivators CantelCompletedInfectionUnited States
-
Yale UniversityNational Institute on Drug Abuse (NIDA)Not yet recruitingCigarette Smoking | Sex Differences | Nicotine Addiction | E-Cig Use
-
Cheerain HK LimitedCompletedElectronic Cigarette UseUnited States
-
Allergy TherapeuticsCompleted
-
DePuy OrthopaedicsTerminatedOsteoarthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Non-inflammatory Joint DiseaseUnited States
-
CHU de Quebec-Universite LavalZimmer BiometCompletedUnilateral Primary Osteoarthritis of KneeCanada
-
UConn HealthCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
University of WaterlooAlcon ResearchCompleted